PF-24463 |
O-PLAT 100 mg. Liofilizado para uso parenteral |
2012-01-04 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24878 |
MODIFICAL 8 mg Solución Inyectable |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|
PF-24879 |
MODIFICAL 4 mg Comprimidos recubiertos |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J.I. Cohen |
Asofarma |
Equimed |
Agefinsa |
Codister |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24881 |
MODIFICAL 8 mg Comprimido recubierto |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|
PF-24880 |
MODIFICAL 4 mg Solución Inyectable |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|
PF-24877 |
TECNOTECAN 100 mg/5mL Solucion inyectable |
2007-03-11 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28724 |
Mitomicina Asofarma 5 mg liofilizado para uso parenteral |
2007-09-24 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29368 |
DOXORUBICINA Farmacéutica Paraguaya 10 mg Polvo liofilizado para uso parenteral |
2017-12-06 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29645 |
LERTUS 25 mg comprimidos recubiertos |
2008-02-05 |
|
Indefa S.a.c.i. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30151 |
YOCON 50 mg comprimidos recubiertos |
2008-03-28 |
|
Indefa S.a.c.i. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|